(Q39657136)

13 September 2017

title

Tumor specific low pH environments enhance the cytotoxicity of lovastatin and cantharidin (English)

1 reference

13 September 2017

0 references

Toshihiko Fukamachi

1

1 reference

13 September 2017

Yoshie Chiba

2

1 reference

13 September 2017

Xin Wang

3

1 reference

13 September 2017

Hiromi Saito

4

1 reference

13 September 2017

Masatoshi Tagawa

5

1 reference

13 September 2017

Hiroshi Kobayashi

6

1 reference

13 September 2017

language of work or name

English

0 references

publication date

17 June 2010

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:S0304383510002867?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

https://api.elsevier.com/content/article/PII:S0304383510002867?httpAccept=text/plain

10 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

10 July 2024

1 reference

13 September 2017

volume

297

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

182-189

1 reference

Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation

13 September 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

On the Origin of Cancer Cells

10 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Influence of low pH on cytotoxicity of paclitaxel, mitoxantrone and topotecan

10 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Acidosis induces multi-drug resistance in rat prostate cancer cells (AT1) in vitro and in vivo by increasing the activity of the p-glycoprotein via activation of p38.

10 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Different proteins are phosphorylated under acidic environments in Jurkat cells

10 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Extracellular acidic environments induce phosphorylation of ZAP-70 in Jurkat T cells

10 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Requirement of an IkappaB-beta COOH terminal region protein for acidic-adaptation in CHO cells.

10 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

CTIB (C-Terminus protein of IkappaB-beta): a novel factor required for acidic adaptation

10 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Biology and management of malignant pleural mesothelioma.

10 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Induction of stem cell factor/c-Kit/slug signal transduction in multidrug-resistant malignant mesothelioma cells

10 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Pancreatic cancer: progress in cancer therapy.

10 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Consensus report of the international society of gastrointestinal oncology on therapeutic progress in advanced pancreatic cancer

10 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial.

10 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Statins and cancer prevention

10 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Differences in antitumor effects of various statins on human pancreatic cancer.

10 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Asbestos induces nitric oxide synthesis in mesothelioma cells via Rho signaling inhibition

10 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Lovastatin induces apoptosis in malignant mesothelioma cells.

10 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Statins revert doxorubicin resistance via nitric oxide in malignant mesothelioma.

10 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Metastasis of B16F10 mouse melanoma inhibited by lovastatin, an inhibitor of cholesterol biosynthesis

10 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Inhibition of lung tumor cell growth in vitro and mouse lung tumor formation by lovastatin

10 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

DNA Interactions of pH-Sensitive, Antitumor Bis(aminoalcohol)dichloroplatinum(II) Complexes†,‡

10 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

10 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

10 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis

10 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

HMG-CoA reductase inhibitor simvastatin overcomes bortezomib-induced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway

10 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma.

10 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

10 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Effect of changes in pH on wall tension in isolated rat pulmonary artery: role of the RhoA/Rho-kinase pathway.

10 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis

10 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant

10 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio.

10 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Cantharidin induces apoptosis of human multiple myeloma cells via inhibition of the JAK/STAT pathway

10 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Molecular biology of cantharidin in cancer cells

10 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Plasmodium falciparum: synchronization of asexual development with aphidicolin, a DNA synthesis inhibitor

10 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Entamoeba invadens: reversible effects of aphidicolin on the growth and encystation

10 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Mammalian mutator mutant with an aphidicolin-resistant DNA polymerase alpha

10 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Checkpoint adaptation in human cells

10 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

10 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.05.010

10 July 2024

Identifiers

1 reference

13 September 2017

1 reference